Laura
Pérez-Martínez
Publicaciones en las que colabora con Laura Pérez-Martínez (10)
2021
2017
-
Maraviroc ameliorates the increased adipose tissue macrophage recruitment induced by a high-fat diet in a mouse model of obesity
Antiviral Therapy, Vol. 22, Núm. 2, pp. 163-168
2015
-
Maraviroc modifica la composición de la microbiota intestinal en un modelo animal de obesidad: Una posible opción terapéutica para prevenir los trastornos metabólicos en pacientes infectados por el VIH
Revista Espanola de Quimioterapia, Vol. 28, Núm. 4, pp. 200-206
2014
-
Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD)
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 7, pp. 1903-1910
2013
-
Multiple frequency bioimpedance is an adequate tool to assess total and regional fat mass in HIV-positive patients but not to diagnose HIV-associated lipoatrophy: A pilot study
Journal of the International AIDS Society, Vol. 16
-
Role of mitochondria in HIV infection and associated metabolic disorders: Focus on nonalcoholic fatty liver disease and lipodystrophy syndrome
Oxidative Medicine and Cellular Longevity
2012
-
Investigación en VIH y Lipodistrofia en el Hospital San Pedro-Cibir: modelos "in vitro" de adipocitos para el estudio de los efectos tóxicos de fármacos antirretrovirales
Zubía, Núm. 24, pp. 129
-
Minimal effects of Darunavir on adipocyte differentiation and metabolism in 3T3-L1 cells
Journal of Infection and Chemotherapy, Vol. 18, Núm. 4, pp. 485-493
2011
-
Neutral actions of raltegravir on Adipogenesis, Glucose metabolism and lipolysis in 3T3-L1 Adipocytes
Current HIV Research, Vol. 9, Núm. 3, pp. 174-179
2010
-
Palpebral ptosis related to antiretroviral therapy: Report of two new cases and review of the literature
HIV and AIDS Review, Vol. 9, Núm. 4, pp. 109-111